Sleep Drug's pregnancy safety under the microscope in major registry

NCT ID NCT06498128

Recruiting now Knowledge-focused Sponsor: Idorsia Pharmaceuticals Ltd. Source: ClinicalTrials.gov ↗

Summary

This study aims to gather safety information on the insomnia medication QUVIVIQ when used during pregnancy. It will follow about 785 women who have insomnia, comparing health outcomes for those who took QUVIVIQ during pregnancy to those who did not. The main goal is to understand potential risks for birth defects and other pregnancy complications to help inform future medical advice.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Azienda Ospedaliera Universitaria Policlinico Tor Vergata
NOT_YET_RECRUITING

Rome, Italy
Charité - Universitätsmedizin Berlin
NOT_YET_RECRUITING

Berlin, Germany
Hospital Txagorritxu
NOT_YET_RECRUITING

Vitoria-Gasteiz, Spain
Hôpital Gui de Chauliac
NOT_YET_RECRUITING

Montpellier, France
IQVIA US Office
RECRUITING

Durham, North Carolina, 27703, United States
Jodha Tishon
NOT_YET_RECRUITING

Toronto, Ontario, Canada
University College London Hospitals
NOT_YET_RECRUITING

London, United Kingdom

Conditions

Explore the condition pages connected to this study.

INSOMNIA